A detailed history of Godshalk Welsh Capital Management, Inc. transactions in Globus Medical Inc stock. As of the latest transaction made, Godshalk Welsh Capital Management, Inc. holds 62,320 shares of GMED stock, worth $5.2 Million. This represents 2.89% of its overall portfolio holdings.

Number of Shares
62,320
Previous 66,445 6.21%
Holding current value
$5.2 Million
Previous $4.55 Million 2.02%
% of portfolio
2.89%
Previous 3.1%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$67.08 - $73.92 $276,705 - $304,920
-4,125 Reduced 6.21%
62,320 $4.46 Million
Q2 2024

Aug 12, 2024

SELL
$49.79 - $68.85 $228,536 - $316,021
-4,590 Reduced 6.46%
66,445 $4.55 Million
Q3 2023

Nov 13, 2023

SELL
$49.1 - $62.37 $49,100 - $62,370
-1,000 Reduced 1.39%
71,035 $3.53 Million
Q1 2023

May 12, 2023

SELL
$51.83 - $79.63 $12,957 - $19,907
-250 Reduced 0.35%
72,035 $4.08 Million
Q4 2022

Feb 13, 2023

SELL
$58.4 - $75.53 $1.51 Million - $1.95 Million
-25,777 Reduced 26.29%
72,285 $5.37 Million
Q3 2022

Nov 14, 2022

BUY
$55.32 - $67.54 $1.38 Million - $1.69 Million
24,961 Added 34.15%
98,062 $5.84 Million
Q1 2022

May 12, 2022

SELL
$63.68 - $75.54 $21,269 - $25,230
-334 Reduced 0.45%
73,101 $5.39 Million
Q4 2021

Feb 14, 2022

SELL
$62.62 - $79.92 $19,600 - $25,014
-313 Reduced 0.42%
73,435 $5.3 Million
Q2 2021

Aug 09, 2021

SELL
$61.85 - $77.53 $106,814 - $133,894
-1,727 Reduced 2.29%
73,748 $5.99 Million
Q1 2021

May 13, 2021

SELL
$60.05 - $67.74 $96,680 - $109,061
-1,610 Reduced 2.09%
75,475 $4.66 Million
Q3 2020

Nov 12, 2020

SELL
$45.26 - $57.82 $20,050 - $25,614
-443 Reduced 0.57%
77,085 $3.82 Million
Q2 2020

Aug 11, 2020

SELL
$39.81 - $55.61 $117,200 - $163,715
-2,944 Reduced 3.66%
77,528 $3.7 Million
Q1 2020

May 06, 2020

SELL
$35.06 - $59.45 $17,775 - $30,141
-507 Reduced 0.63%
80,472 $3.42 Million
Q4 2019

Feb 10, 2020

SELL
$49.45 - $59.5 $115,020 - $138,397
-2,326 Reduced 2.79%
80,979 $4.77 Million
Q3 2019

Nov 12, 2019

SELL
$40.41 - $52.32 $72,859 - $94,332
-1,803 Reduced 2.12%
83,305 $4.26 Million
Q2 2019

Aug 09, 2019

SELL
$39.3 - $48.41 $23,540 - $28,997
-599 Reduced 0.7%
85,108 $3.6 Million
Q1 2019

May 09, 2019

SELL
$38.08 - $49.41 $59,633 - $77,376
-1,566 Reduced 1.79%
85,707 $4.24 Million
Q4 2018

Feb 12, 2019

SELL
$41.38 - $57.44 $46,966 - $65,194
-1,135 Reduced 1.28%
87,273 $3.78 Million
Q3 2018

Nov 09, 2018

BUY
$50.24 - $56.76 $1.67 Million - $1.89 Million
33,320 Added 60.49%
88,408 $5.02 Million
Q2 2018

Aug 10, 2018

SELL
$47.96 - $57.41 $127,141 - $152,193
-2,651 Reduced 4.59%
55,088 $2.78 Million
Q1 2018

May 10, 2018

SELL
$42.75 - $51.73 $305,790 - $370,024
-7,153 Reduced 11.02%
57,739 $2.88 Million
Q4 2017

Feb 13, 2018

SELL
$28.86 - $41.64 $42,424 - $61,210
-1,470 Reduced 2.22%
64,892 $2.67 Million
Q2 2017

Aug 14, 2017

BUY
N/A
66,362
66,362 $2.2 Million

Others Institutions Holding GMED

About GLOBUS MEDICAL INC


  • Ticker GMED
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 77,037,200
  • Market Cap $6.43B
  • Description
  • Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...
More about GMED
Track This Portfolio

Track Godshalk Welsh Capital Management, Inc. Portfolio

Follow Godshalk Welsh Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Godshalk Welsh Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Godshalk Welsh Capital Management, Inc. with notifications on news.